Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Net Sales	$ 1,762.2	$ 1,106.0	$ 4,064.2	$ 3,450.4
Cost of products sold, excluding intangible asset amortization	552.1	295.9	1,131.3	929.0
Intangible asset amortization	122.6	20.6	176.0	72.0
Research and development	83.3	45.9	182.9	141.1
Selling, general and administrative	692.3	422.8	1,560.6	1,311.5
Certain claims (Note 17)		(0.3)	7.7	21.5
Special items (Note 3)	195.9	65.9	751.9	164.3
Operating expenses	1,646.2	850.8	3,810.4	2,639.4
Operating Profit	116.0	255.2	253.8	811.0
Other income (expense), net	4.3	(12.1)	(44.6)	(25.4)
Interest income	2.3	3.0	7.4	8.4
Interest expense	(90.8)	(16.3)	(196.6)	(47.1)
Earnings before income taxes	31.8	229.8	20.0	746.9
Provision for income taxes	9.6	56.9	0.5	181.4
Net Earnings	22.2	172.9	19.5	565.5
Less: Net loss attributable to noncontrolling interest		(0.2)	(0.5)	(1.0)
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 22.2	$ 173.1	$ 20.0	$ 566.5
Earnings Per Common Share
Basic	$ 0.11	$ 1.02	$ 0.11	$ 3.36
Diluted	$ 0.11	$ 1.01	$ 0.11	$ 3.30
Weighted Average Common Shares Outstanding
Basic	203.5	169.0	182.1	168.8
Diluted	205.7	171.7	184.7	171.5
Cash Dividends Declared Per Common Share	$ 0.22	$ 0.22	$ 0.66	$ 0.66